AU Patent

AU2023209820B2 — Parp1 inhibitors and uses thereof

Assigned to Xinthera Inc · Expires 2024-10-10 · 2y expired

What this patent protects

Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.

USPTO Abstract

Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023209820B2
Jurisdiction
AU
Classification
—
Expires
2024-10-10
Drug substance claim
No
Drug product claim
No
Assignee
Xinthera Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.